Press release
Ventricular Drainage Sets: Market 2018 Detailed Global Analysis by Top Key Players – Integra LifeSciences Corporation, Medtronic plc, Fuji Systems Corporation, Moller Medical GmbH, Sophysa, Dispomedica, and Spiegelberg GmbH & Co. KG.
The Ventricular Drainage Sets Market is expected to have a highly positive outlook for the next five years 2018-2026 according to a recently released Ventricular Drainage Sets Market research report. The report has been added in his large database by Coherent Market Insights.The major takeaways in the report are product segment analysis, application segment analysis, regional segment analysis and data of the major Ventricular Drainage Sets Market players from around the world. The report presents an introductory as well as detailed information about the Ventricular Drainage Sets Market through a well-organized layout divided into easy to understand chapters.
Click Here for Sample of “Global Ventricular Drainage Sets Market” Report Visit @ https://www.coherentmarketinsights.com/insight/request-sample/1926
Ventricular Drainage Sets Market - Regional Analysis
The global ventricular drainage sets market is segmented in North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America ventricular drainage sets market is expected to hold dominant position in the market. This is owing to increasing demand from rising hospitalizations associated with traumatic brain injury. For instance, according to Morbidity and Mortality Weekly Report (MMWR) Surveillance Summaries 2017, the rate of traumatic brain injury related emergency department visits in the U.S. increased by 47% whereas death rates decreased by 5%, over the duration of six years (2007–2013). The decrease in death rate is expected to be due to increasing adoption of medical equipment to better serve the patients.
Major companies operating in the global ventricular drainage sets market include Integra LifeSciences Corporation, Medtronic plc, Fuji Systems Corporation, Moller Medical GmbH, Sophysa, Dispomedica, and Spiegelberg GmbH & Co. KG.
Ventricular Drainage Sets Market - Taxonomy
Based on product type:
-Ventricular Drainage Set
-Accessories (catheters and external ventricular drainage bag)
Based on application:
-Intraventricular Hemorrhage
-Intracranial Hypertension
-Hydrocephalus
-CSF Infection
-Others
Based on end user:
-Hospitals
-Ambulatory Surgical Centers
Based on region:
-North America
-Europe
-Latin America
-Asia Pacific
-Middle East
-Africa
Else place an Inquire before Purchase “Global Ventricular Drainage Sets Market Size, Status and Forecast 2026": https://www.coherentmarketinsights.com/insight/talk-to-analyst/1926
Ventricular Drainage Sets Market Dynamics
High incidence of intraventricular hemorrhage associated with premature baby birth is expected to drive the ventricular drainage sets market growth over the forecast period. According to study published in Child’s Nervous System, 2016, intraventricular hemorrhage is commonly observed in 15%-20% of babies born before 32 weeks of gestation.
Furthermore, rising incidence of neurological disorders is leading to increasing demand for ventricular drainage sets, in turn propelling the ventricular drainage sets market growth. According to American Neurological Association, 2017, annual incidence of traumatic brain injury in the U.S. ranges from 1.4 million to 1.7 million. Moreover, the rate of traumatic injury increases with increasing age due to weakened neurological response.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ventricular Drainage Sets: Market 2018 Detailed Global Analysis by Top Key Players – Integra LifeSciences Corporation, Medtronic plc, Fuji Systems Corporation, Moller Medical GmbH, Sophysa, Dispomedica, and Spiegelberg GmbH & Co. KG. here
News-ID: 1362177 • Views: 325
More Releases from Coherent Market Insights - Medical Devices

Gamma Knife Market: Region Wise Analysis of Top Players in Market by its Types a …
The global gamma knife market was valued at US$ 174.4 million in 2016 and is expected to expand at a CAGR of 7.7% during the forecast period (2017 – 2025). Chronic neurological disorders such as metastatic brain tumors, trigeminal neuralgia, and arteriovenous malformations are complex to treat. Standard brain surgery and radiation therapy can damage healthy tissues and cause various side effects. Moreover, these treatment methods involve in-hospital post treatment…

Fetal Monitoring Market By Worldwide Analysis, Estimation, Industry Applications …
Fetal monitoring devices are used to monitor the heart rate and movement of the fetus and maternal contractions. In medical terms, fetal monitoring is imperative to constantly monitor health of the unborn baby and ensure a safe birth. Fetal monitoring measures the heart rate of the baby. Healthcare providers perform fetal monitoring during late pregnancy and labor, as that process is crucial for keeping the mother and the child safe…

Global Continuous Glucose Monitoring (CGM) Market Includes Latest Key Developmen …
Diabetes is a major global concern that, as per International Diabetes Federation (IDF) data, affected around 415 million people in 2015. Effective management of diabetes is vital, especially considering the sedentary lifestyle that most people across the globe have taken up. Continuous glucose monitoring (CGM) systems offer effective solution in diabetes management through continuous real-time glucose monitoring. Increasing awareness, supporting safety evidences for CGM systems and growing demand for point-of-care…

Insulin Pumps Market Report 2018-2026 Focuses On Top Companies Medtronics, Braun …
Insulin pump is a portable device attached to the body that continuously delivers preset amounts of short or rapid acting insulin in the body to control diabetes. Insulin therapy is required in type 1 diabetes and sometime in type 2 diabetes. It serves as an effective alternative to insulin injections. Furthermore, insulin pump delivers the insulin according to the need of body as basal rate, where small amount of insulin…
More Releases for Ventricular
Ventricular Assist Device Market Report Up tp 2031
Visiongain has published a new report on Ventricular Assist Device Market Report 2021-2031: Forecasts by Product (LVAD, RVAD, BiVAD, TAH), By Type of Flow (Pulsatile, Continuous), By Design, By Application. PLUS Profiles of Leading Pharma Contract Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.
GlobalVentricular Assist Device market was valued at US$ xx billion in 2020 and is projected to reach at a market value of…
Left Ventricular Dysfunction - Pipeline Review, H1 2018
Left Ventricular Dysfunction
Overview
Left ventricular dysfunction is the most common cause of congestive heart failure. Symptoms include fluid retention, dizziness, fatigue, weakness, irregular heart beat and congested lungs. Risk factors include high blood pressure, diabetes, sleep apnea, alcoholism and Left Ventricular Dysfunction.
Click here for sample report @ https://www.wiseguyreports.com/sample-request/2811435-left-ventricular-dysfunction-pipeline-review-h1-2018
Top Companies mentioned
Bayer AG
Innopharmax Inc
Mesoblast Ltd
Novartis AG
Quantum Genomics SA
TiGenix NV
Left Ventricular Dysfunction Industry Major Outlook
Pharmaceutical and Healthcare latest pipeline guide Left Ventricular Dysfunction -…
Left Ventricular Dysfunction - Pipeline Review, H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Left Ventricular Dysfunction - Pipeline Review, H1 2017, provides an overview of the Left Ventricular Dysfunction (Cardiovascular) pipeline landscape.
Left ventricular dysfunction is the most common cause of congestive heart failure. Symptoms include fluid retention, dizziness, fatigue, weakness, irregular heart beat and congested lungs. Risk factors include high blood pressure, diabetes, sleep apnea, alcoholism and coronary artery disease.
Report Highlights
Publisher's Pharmaceutical and Healthcare…
Global Ventricular Fibrillation Market 2021- Analysis and Trends
“Global Ventricular Fibrillation Market Research Report” Purchase This Report by calling ResearchnReports.com at +1-888-631-6977.
Ventricular fibrillation is a heart rhythm problem that occurs when the heart beats with rapid, erratic electrical impulses. This causes pumping chambers in your heart (the ventricles) to quiver uselessly, instead of pumping blood. Together, all four chambers pump blood to and from the body. When the atria, the two upper chambers, contract at an excessively high…
Ventricular Assist Devices (VAD) Market Assessment
Ventricular assist devices (VAD) are mechanical pumps used to support patients with a weakened heart or in case of heart failure to temporarily maintain heart function. The devices helps in re-establishing normal hemodynamics under conditions involving damaged ventricle. Increasing trend for sedentary lifestyle, rising obesity population globally, lifestyle changes and various other factors have resulted an increase in cardiovascular disorders. This rising prevalence across the globe has been a major…
Ventricular Assist Device Market: Global Markets & Advanced Technologies
North America Ventricular Assist Device Market: Overview
Advance Heart Failure is characterized as weakening of the heart caused due to failure of the left ventricle, due to which the heart is unable to pump blood to different parts of the body. According to the AHA (American Heart Association), 5.7 Mn people in the U.S suffer from heart failure and 300,000 die each year of heart failure. Moreover, the AHA predicts…